RABEP2
Basic information
Region (hg38): 16:28904421-28936526
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RABEP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 32 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 33 | 2 | 3 |
Variants in RABEP2
This is a list of pathogenic ClinVar variants found in the RABEP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-28904492-G-A | Brody myopathy | Uncertain significance (Jan 12, 2018) | ||
16-28904503-C-T | Brody myopathy | Benign (Jan 13, 2018) | ||
16-28905025-C-T | not specified | Uncertain significance (May 06, 2022) | ||
16-28905032-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
16-28905054-C-T | Benign (Dec 31, 2019) | |||
16-28905420-C-T | not specified | Uncertain significance (Jan 11, 2023) | ||
16-28905467-C-T | not specified | Uncertain significance (Jun 22, 2024) | ||
16-28905724-C-A | not specified | Uncertain significance (Sep 01, 2021) | ||
16-28905726-C-T | not specified | Uncertain significance (May 18, 2023) | ||
16-28905873-G-C | not specified | Uncertain significance (Jul 13, 2022) | ||
16-28906096-A-G | not specified | Uncertain significance (Jan 23, 2023) | ||
16-28906121-G-A | not specified | Uncertain significance (Aug 26, 2022) | ||
16-28906168-C-T | not specified | Likely benign (Mar 29, 2022) | ||
16-28908610-G-T | not specified | Uncertain significance (May 06, 2024) | ||
16-28908650-G-T | not specified | Uncertain significance (May 27, 2022) | ||
16-28908692-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
16-28908719-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
16-28908723-T-C | Benign (Jan 30, 2018) | |||
16-28908732-G-C | not specified | Uncertain significance (Mar 19, 2024) | ||
16-28910938-T-A | not specified | Uncertain significance (Sep 15, 2021) | ||
16-28911137-G-A | not specified | Uncertain significance (Feb 13, 2024) | ||
16-28911149-C-G | not specified | Uncertain significance (Apr 20, 2023) | ||
16-28911149-C-T | not specified | Likely benign (Nov 08, 2021) | ||
16-28911171-C-G | not specified | Uncertain significance (Nov 09, 2023) | ||
16-28914324-G-A | not specified | Uncertain significance (May 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RABEP2 | protein_coding | protein_coding | ENST00000358201 | 13 | 32106 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00114 | 0.999 | 124731 | 0 | 74 | 124805 | 0.000297 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.432 | 337 | 360 | 0.936 | 0.0000243 | 3599 |
Missense in Polyphen | 65 | 73.254 | 0.88732 | 740 | ||
Synonymous | 0.626 | 156 | 166 | 0.938 | 0.0000109 | 1198 |
Loss of Function | 3.43 | 11 | 31.9 | 0.344 | 0.00000162 | 334 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000684 | 0.000678 |
Ashkenazi Jewish | 0.00402 | 0.00368 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000164 | 0.000150 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.0000659 | 0.0000654 |
Other | 0.000186 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in membrane trafficking and in homotypic early endosome fusion. {ECO:0000269|PubMed:9524116}.;
Recessive Scores
- pRec
- 0.239
Intolerance Scores
- loftool
- 0.502
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 15.12
Haploinsufficiency Scores
- pHI
- 0.246
- hipred
- N
- hipred_score
- 0.372
- ghis
- 0.650
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.104
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rabep2
- Phenotype
Gene ontology
- Biological process
- endocytosis;regulation of signaling receptor activity;protein transport;positive regulation of GTPase activity
- Cellular component
- early endosome;cytosol;intracellular membrane-bounded organelle
- Molecular function
- GTPase activator activity;growth factor activity